Hillhouse Capital Management as of June 30, 2018
Portfolio Holdings for Hillhouse Capital Management
Hillhouse Capital Management holds 54 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alibaba Group Holding (BABA) | 20.6 | $1.2B | 6.5M | 185.53 | |
| Beigene (BGNE) | 14.3 | $841M | 5.5M | 153.73 | |
| Jd (JD) | 14.1 | $826M | 21M | 38.95 | |
| 58 Com Inc spon adr rep a | 6.3 | $371M | 5.3M | 69.34 | |
| Enstar Group (ESGR) | 6.2 | $362M | 1.7M | 207.30 | |
| Fibrogen (FGEN) | 2.9 | $168M | 2.7M | 62.60 | |
| Melco Crown Entertainment (MLCO) | 2.5 | $149M | 5.3M | 28.00 | |
| Mondelez Int (MDLZ) | 2.5 | $145M | 3.5M | 41.00 | |
| Snap Inc cl a (SNAP) | 2.5 | $144M | 11M | 13.09 | |
| Electronic Arts (EA) | 2.0 | $115M | 815k | 141.02 | |
| Iqiyi (IQ) | 1.9 | $112M | 3.5M | 32.30 | |
| Baidu (BIDU) | 1.8 | $108M | 445k | 243.00 | |
| Netflix (NFLX) | 1.8 | $104M | 265k | 391.43 | |
| Kiniksa Pharmaceuticals | 1.7 | $100M | 5.7M | 17.35 | |
| Apellis Pharmaceuticals (APLS) | 1.6 | $95M | 4.3M | 22.00 | |
| REPCOM cla | 1.6 | $95M | 943k | 100.47 | |
| Blueprint Medicines (BPMC) | 1.6 | $91M | 1.4M | 63.48 | |
| Tripadvisor (TRIP) | 1.3 | $76M | 1.4M | 55.71 | |
| Bright Scholar Ed Hldgs | 1.2 | $71M | 4.3M | 16.63 | |
| NetEase (NTES) | 1.1 | $67M | 265k | 252.67 | |
| China Biologic Products | 1.1 | $61M | 618k | 99.33 | |
| Ikang Healthcare Group- | 1.0 | $60M | 2.9M | 20.46 | |
| Line Corp- | 0.8 | $50M | 1.2M | 41.07 | |
| Noah Holdings (NOAH) | 0.8 | $47M | 892k | 52.15 | |
| Myokardia | 0.7 | $43M | 858k | 49.65 | |
| TAL Education (TAL) | 0.6 | $34M | 924k | 36.80 | |
| Acceleron Pharma | 0.6 | $34M | 700k | 48.52 | |
| G1 Therapeutics | 0.5 | $30M | 699k | 43.46 | |
| Sohu (SOHU) | 0.5 | $29M | 802k | 35.50 | |
| Facebook Inc cl a (META) | 0.4 | $23M | 119k | 194.32 | |
| Uxin Ltd ads | 0.4 | $23M | 2.5M | 9.04 | |
| Moody's Corporation (MCO) | 0.3 | $15M | 90k | 170.56 | |
| Berkshire Hathaway (BRK.A) | 0.2 | $14M | 51.00 | 282039.22 | |
| Charles Schwab Corporation (SCHW) | 0.2 | $14M | 272k | 51.10 | |
| Loxo Oncology | 0.2 | $14M | 81k | 173.48 | |
| Puxin Ltd ads | 0.2 | $14M | 629k | 21.40 | |
| Liberty Global Inc C | 0.2 | $13M | 473k | 26.61 | |
| Verisign (VRSN) | 0.2 | $10M | 76k | 137.42 | |
| Gs Acquisition Hldgs Corp unit 06/12/2023 | 0.2 | $10M | 1.0M | 10.20 | |
| Incyte Corporation (INCY) | 0.2 | $9.6M | 143k | 67.00 | |
| Arcus Biosciences Incorporated (RCUS) | 0.2 | $9.4M | 767k | 12.24 | |
| Neon Therapeutics | 0.1 | $9.0M | 712k | 12.60 | |
| Greentree Hospitalty Group L (GHG) | 0.1 | $7.7M | 425k | 18.09 | |
| IDEXX Laboratories (IDXX) | 0.1 | $7.3M | 33k | 217.94 | |
| China Jo Jo Drugstores | 0.1 | $7.0M | 4.8M | 1.44 | |
| Fang Hldgs | 0.1 | $5.8M | 1.5M | 3.88 | |
| Nektar Therapeutics (NKTR) | 0.1 | $5.2M | 108k | 48.83 | |
| S&p Global (SPGI) | 0.1 | $5.0M | 24k | 203.88 | |
| Eidos Therapeutics | 0.1 | $4.6M | 225k | 20.34 | |
| CIGNA Corporation | 0.1 | $3.8M | 22k | 169.96 | |
| Proteostasis Therapeutics In | 0.0 | $2.4M | 866k | 2.79 | |
| Nabriva Therapeutics | 0.0 | $2.5M | 716k | 3.48 | |
| Solid Biosciences | 0.0 | $2.5M | 70k | 35.63 | |
| Tesaro | 0.0 | $1.6M | 37k | 44.47 |
